Garlic Phytocompounds Possess Anticancer Activity by Specifically Targeting Breast Cancer Biomarkers - an in Silico

Nabarun Roy1, Sangeetha Davis, Arunaksharan Narayanankutty

  • 1Distributed Information Centre, Kerala Agricultural University, Kerala, India

Abstract

Insights

Researchers identified twelve active compounds from garlic with potential anti-cancer properties. These compounds showed good interactions with breast cancer (BC) targets, offering a natural source for drug discovery.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Computational Chemistry

Background:

  • Breast cancer (BC) is a significant lifestyle disease.
  • Nuclear receptors are prognostic biomarkers associated with BC characteristics.
  • Identifying safe, plant-derived compounds for therapeutic intervention is crucial.

Purpose of the Study:

  • To identify potential anti-cancer compounds from garlic.
  • To evaluate the interaction of garlic compounds with BC-related targets.
  • To assess the drug-likeness and safety profile of identified compounds.

Main Methods:

  • Compounds from garlic and BC targets were retrieved from PubChem and Protein Data Bank.
  • Molecular docking was performed using Accelrys Discovery Studio (DS) 4.0.
  • Drug-likeness and ADMET properties were evaluated for selected compounds.

Main Results:

  • Twelve compounds from garlic demonstrated activity against BC targets.
  • Docking studies revealed highly negative dock scores, indicating strong interactions.
  • ADMET evaluation supported the potential therapeutic utility of these compounds.

Conclusions:

  • Garlic contains compounds with significant potential for breast cancer treatment.
  • The identified compounds can serve as a basis for developing novel pharmaceutical drugs.
  • This research aids in the discovery of natural product-based therapeutics for breast cancer.

Related Concept Videos